ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...

There's nothing swampier than handing over billions of taxpayer dollars to a pharmaceutical company that had already gotten rich off the coronavirus pandemic.

When people undergo radiotherapy for cancer, it's not just the tumor that suffers. The radiation causes DNA breaks in healthy ...

This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.

Generation Bio (NASDAQ:GBIO – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Wednesday, March 5th. Analysts expect Generation Bio to post earnings of ...

YolTech Therapeutics reports positive clinical data for YOLT-203, an in vivo gene editing therapy for primary hyperoxaluria type 1: Shanghai, China Wednesday, February 26, 2025, 1 ...

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...

Following these changes, the company has also seen the addition of four new directors * Robert Alan Beardsley, Joseph Bishop, ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced significant changes to its leadership team, naming Lindsay ...

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...